The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin
Myalgia, Muscle Pain, Orofacial Pain
About this trial
This is an interventional treatment trial for Myalgia focused on measuring cannabidiol, cannabinol
Eligibility Criteria
Inclusion Criteria: facial pain and headache of muscular origin for more than 3 months Exclusion Criteria: patients under 18 years of age, patients who are allergic to any ingredient of the preparation, pregnant or breast-feeding women, patients taking preparations that contain similar ingredients and/or have similar effects, obese patients, patients with active cancer, patients with severe systemic diseases, including genetic and neurological diseases, patients with severe mental illnesses, patients who are taking or in the last 12 months have taken antidepressants and/or myorelaxants and/or other drugs that affect neuromuscular activity, patients addicted to alcohol or drugs.
Sites / Locations
- Wroclaw Medical University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Study Group
Control group
Participants with facial pain and headache of muscular origin which last for more than 3 months. Each of the participants in this group will receive the aqueous solution of CBD and CBN to drink in home every day for 60 days in a specific dose determined by the attending physician
Participants with facial pain and headache of muscular origin which last for more than 3 months. Each of the participants in this group will receive the placebo to drink in home every day for 60 days in a specific dose determined by the attending physician